Free Trial

American Century Companies Inc. Sells 191,186 Shares of Haleon plc (NYSE:HLN)

Haleon logo with Medical background

American Century Companies Inc. trimmed its holdings in Haleon plc (NYSE:HLN - Free Report) by 20.0% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 764,349 shares of the company's stock after selling 191,186 shares during the quarter. American Century Companies Inc.'s holdings in Haleon were worth $6,314,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently modified their holdings of the company. Janney Montgomery Scott LLC boosted its holdings in shares of Haleon by 182.3% during the 1st quarter. Janney Montgomery Scott LLC now owns 438,833 shares of the company's stock valued at $3,726,000 after acquiring an additional 283,410 shares during the last quarter. Capstone Investment Advisors LLC bought a new stake in Haleon during the 1st quarter worth approximately $1,969,000. Wellington Management Group LLP raised its stake in Haleon by 164.6% during the 4th quarter. Wellington Management Group LLP now owns 13,542,346 shares of the company's stock worth $111,454,000 after acquiring an additional 8,423,475 shares during the period. Douglas Lane & Associates LLC raised its stake in Haleon by 2.1% during the 1st quarter. Douglas Lane & Associates LLC now owns 8,401,876 shares of the company's stock worth $71,332,000 after acquiring an additional 175,082 shares during the period. Finally, Procyon Advisors LLC raised its stake in Haleon by 559.9% during the 1st quarter. Procyon Advisors LLC now owns 131,665 shares of the company's stock worth $1,118,000 after acquiring an additional 111,713 shares during the period. 6.67% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the stock. The Goldman Sachs Group cut shares of Haleon from a "buy" rating to a "neutral" rating in a research report on Tuesday, August 6th. Morgan Stanley lifted their price objective on shares of Haleon from $9.90 to $10.95 and gave the company an "overweight" rating in a research report on Friday, September 20th. Finally, Berenberg Bank assumed coverage on shares of Haleon in a research report on Tuesday, August 6th. They set a "buy" rating on the stock. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $10.95.

Get Our Latest Report on Haleon

Haleon Trading Down 0.7 %

NYSE HLN traded down $0.07 on Wednesday, hitting $10.59. 6,404,319 shares of the stock were exchanged, compared to its average volume of 4,935,614. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84. The stock has a fifty day moving average price of $9.84 and a two-hundred day moving average price of $8.91. The firm has a market capitalization of $48.26 billion, a P/E ratio of 35.60, a P/E/G ratio of 3.12 and a beta of 0.26. Haleon plc has a 52-week low of $7.70 and a 52-week high of $10.76.

Haleon (NYSE:HLN - Get Free Report) last issued its earnings results on Thursday, August 1st. The company reported $0.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.09 by ($0.01). The company had revenue of $3.50 billion for the quarter, compared to analysts' expectations of $3.55 billion. Haleon had a net margin of 9.71% and a return on equity of 13.15%. During the same period in the prior year, the firm posted $0.08 earnings per share. Research analysts forecast that Haleon plc will post 0.47 EPS for the current fiscal year.

Haleon Cuts Dividend

The business also recently announced a semi-annual dividend, which was paid on Thursday, September 19th. Stockholders of record on Friday, August 16th were paid a dividend of $0.0514 per share. This represents a dividend yield of 1.6%. The ex-dividend date of this dividend was Friday, August 16th. Haleon's dividend payout ratio is currently 36.67%.

About Haleon

(Free Report)

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.

Further Reading

Institutional Ownership by Quarter for Haleon (NYSE:HLN)

Should you invest $1,000 in Haleon right now?

Before you consider Haleon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Haleon wasn't on the list.

While Haleon currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

AST SpaceMobile Takes Major Leap in Global Connectivity with Satellite Launch
Why Congress Is Betting Big on Broadcom in 2024
What the Bulls and Bears Are Saying About NVIDIA Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines